Cai Wenwu, Li Xin, Shu Chang, Qiu Jian, Fang Kun, Li Ming, Chen Yangxi, Liu Dingxiao
Department of Vascular Surgery, Second Xiangya Hospital, Central South University, Changsha, Hunan, P.R. China.
Department of Vascular Surgery, Second Xiangya Hospital, Central South University, Changsha, Hunan, P.R. China.
Ann Vasc Surg. 2015 Jul;29(5):934-40. doi: 10.1016/j.avsg.2015.01.010. Epub 2015 Mar 7.
The purpose of this study is to compare the clinical outcomes of endovascular versus open revascularization for chronic mesenteric ischemia (CMI).
Published studies that investigated endovascular versus open revascularization for CMI were identified, and meta-analysis was used for statistical analysis.
Eight studies were analyzed by meta-analysis method, cumulative 569 cases were included. Endovascular treatments were performed in 209 cases, and open repairs were performed in 360 cases. Meta-analysis showed that there was no difference in 30-day mortality and 3-year cumulative survival rate between the endovascular group and the open group (P = 0.55 and P = 0.56); compared with the open revascularization group, the endovascular revascularization group resulted in significantly lower rate of in-hospital complication (P = 0.002), while recurrence rate within 3 years after revascularization was significantly greater in the endovascular revascularization group (P < 0.00001).
Endovascular treatment offers a benefit of lower in-hospital complication rate, but a greater recurrence rate within 3 years after revascularization compared with the open revascularization, and both groups have similar 30-day mortality and 3-year cumulative survival rate.
本研究旨在比较慢性肠系膜缺血（CMI）血管内修复与开放血管重建的临床疗效。
检索已发表的关于CMI血管内修复与开放血管重建的研究，并采用荟萃分析进行统计分析。
采用荟萃分析方法分析了8项研究，共纳入569例病例。其中209例行血管内治疗，360例行开放修复。荟萃分析显示，血管内治疗组与开放手术组在30天死亡率和3年累积生存率方面无差异（P = 0.55和P = 0.56）；与开放血管重建组相比，血管内血管重建组的院内并发症发生率显著降低（P = 0.002），而血管内血管重建组血管重建后3年内的复发率显著更高（P < 0.00001）。
与开放血管重建相比，血管内治疗具有降低院内并发症发生率的优势，但血管重建后3年内复发率更高，且两组的30天死亡率和3年累积生存率相似。
